Shares of Aflac (NYSE:AFL) were unchanged in after-market trading after the company reported Q2 results.
Earnings per share increased 13.27% over the past year to $1.28, which beat the estimate of $1.06.
Revenue of $5,407,000,000 decreased by 1.89% year over year, which missed the estimate of $5,430,000,000.
Earnings guidance hasn't been issued by the company for now.
Aflac hasn't issued any revenue guidance for the time being.
Recent Stock Performance
52-week high: $55.07
52-week low: $23.07
Price action over last quarter: down 2.55%
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.